Acute Ischemic Stroke Diagnosis and Treatment Market Expected to Reach US$1.869 bn Before End of 2020

Acute ischemic strokes imply the loss of brain function created by the lack of blood supply to the brain. The most common cause of acute ischemic strokes is the formation of atherosclerosis plaques that narrow or block blood vessels. Another major cause is the formation of blood clots in the arteries to the brain.

According to the report, the primary factor responsible for the current growth rate of the global acute ischemic stroke diagnosis and treatment market is the increasing prevalence of the disease. This market’s growth rate is further supported by the developments that modern medicine and medical devices are allowing in it. Due to the incorporation of these developments, the success rate of surgeries is improving the world over, causing a higher growth rate to show over the given forecast period.

Download Free Sample Report Brochure PDF:

The report’s users can gain deep insights into the acute ischemic stroke diagnosis and treatment market based on its segmented analysis, through the categories of surgery type and diagnostic type. According to surgery type, this market is segmented into endovascular mechanical thrombectomy, angioplasty, and carotid endarterectomy.

Based on surgery type, this market was dominated by carotid endaterectomy in 2013, owing to easier availability, shorter length of treatment time, and a greater success rate. This segment could, however, experience a fall in market shares due to the presence of major side effects.

Based on diagnostic type, this market is segmented into nuclear imaging, cerebral angioplasty, ultrasound, magnetic resonance imaging, computed tomography, and others. Although CT has dominated the global acute ischemic stroke diagnosis and treatment market so far, it is expected to be steadily replaced by the MRI method, owing to higher efficiency and lower costs.

The report also provides a detailed geographical review of the acute ischemic stroke diagnosis and treatment market by segmenting it into the major zones of North America, Asia Pacific, Europe, and the Rest of the World.

Owing to a high patient pool and the presence of highly advanced technologies, this market was dominated by North America in 2013. The second-largest region in the acute ischemic stroke diagnosis and treatment market is Europe, owing to the rapidly increasing geriatric population across this region.

Meanwhile, Asia Pacific is showing the fastest growth rate among all major regions. This is attributed to the surging healthcare industry, the growing population density, and the rising rates of awareness and healthcare expenditures.

The key players in the global acute ischemic stroke diagnosis and treatment market are Hitachi, Ltd., GE Healthcare, Johnson & Johnson, Stryker Corporation, Penumbra, Inc., Philips Healthcare, Siemens Healthcare, Abbott Laboratories, and Covidien plc.

Browse Full Report@
About Us:-
Transparency Market Research is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us:-
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Designed by
Powered by